ArticleHealth affairs scholar2026
Telehealth use among US adults with type 2 diabetes: differences in medication fill patterns and care processes.
Article in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The expansion of telehealth following the COVID-19 pandemic has enhanced access to care, but questions remain about how well telehealth supports the delivery of comprehensive, guideline-concordant care for type 2 diabetes. Methods: We conducted an observational cross-sectional study using nationally representative survey data from the 2021-2023 Medical Expenditures Panel Survey to make unadjusted descriptive comparisons between adults with any diabetes-related telehealth use and those receiving only in-person diabetes care. Results: Of 4348 respondents who had at least one visit for type 2 diabetes from 2021 to 2023, 90.7% had only in-person visits, whereas 9.3% had ≥1 telehealth visits. Insulin prescriptions were more common among telehealth users compared to nonusers (47.5% [95% CI, 41.0%-54.1%] vs 34.4% [95%CI, 32.1%-36.7%]). Conclusion: Overall, this study provides current national data on patterns of telehealth use among US adults with type 2 diabetes. Differences in insulin prescription fill patterns may reflect greater clinical complexity and care needs among patients who use telehealth. These findings offer important context for policy-makers and health systems as they evaluate the role of telehealth in managing chronic disease and consider how virtual care models can be implemented while maintaining high-quality diabetes care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.